Welcome to LookChem.com Sign In|Join Free

CAS

  • or

666179-93-7

1-BOC-4-CYANO-4-(3,4-DIMETHOXYPHENYL)-PIPERIDINE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

666179-93-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 666179-93-7 Structure

  • Basic information

    1. Product Name: 1-BOC-4-CYANO-4-(3,4-DIMETHOXYPHENYL)-PIPERIDINE
    2. Synonyms: 1-BOC-4-CYANO-4-(3,4-DIMETHOXYPHENYL)-PIPERIDINE
    3. CAS NO:666179-93-7
    4. Molecular Formula: C19H26N2O4
    5. Molecular Weight: 346.424
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 666179-93-7.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 1-BOC-4-CYANO-4-(3,4-DIMETHOXYPHENYL)-PIPERIDINE(CAS DataBase Reference)
    10. NIST Chemistry Reference: 1-BOC-4-CYANO-4-(3,4-DIMETHOXYPHENYL)-PIPERIDINE(666179-93-7)
    11. EPA Substance Registry System: 1-BOC-4-CYANO-4-(3,4-DIMETHOXYPHENYL)-PIPERIDINE(666179-93-7)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 666179-93-7(Hazardous Substances Data)

666179-93-7 Usage

Chemical class

Piperidine derivative

Structure

Contains a 4-cyano-4-(3,4-dimethoxyphenyl) group

Protection group

BOC-protected amine (tert-butyloxycarbonyl group)

Application

Used in organic synthesis as a building block for pharmaceuticals and bioactive compounds

Versatility

Serves as a versatile intermediate in the synthesis of complex molecules

Usage

Widely used in medicinal chemistry research and drug discovery

Check Digit Verification of cas no

The CAS Registry Mumber 666179-93-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,6,6,1,7 and 9 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 666179-93:
(8*6)+(7*6)+(6*6)+(5*1)+(4*7)+(3*9)+(2*9)+(1*3)=207
207 % 10 = 7
So 666179-93-7 is a valid CAS Registry Number.

666179-93-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 4-cyano-4-(3,4-dimethoxyphenyl)piperidine-1-carboxylate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:666179-93-7 SDS

666179-93-7Relevant articles and documents

Highly potent PDE4 inhibitors with therapeutic potential

Ochiai, Hiroshi,Ohtani, Tazumi,Ishida, Akiharu,Kusumi, Kensuke,Kato, Masashi,Kohno, Hiroshi,Odagaki, Yoshihiko,Kishikawa, Katuya,Yamamoto, Susumu,Takeda, Hiroshi,Obata, Takaaki,Nakai, Hisao,Toda, Masaaki

, p. 4645 - 4665 (2007/10/03)

Synthesis and biological evaluation of piperidine derivatives is reported. The hypothesis that the dose-limiting side effects of PDE4 inhibitors could be mediated via the central nervous system prompted us to design and synthesize a hydrophilic piperidine

Highly potent PDE4 inhibitors with therapeutic potential

Ochiai, Hiroshi,Ohtani, Tazumi,Ishida, Akiharu,Kusumi, Kensuke,Kato, Masashi,Kohno, Hiroshi,Kishikawa, Katuya,Obata, Takaaki,Nakai, Hisao,Toda, Masaaki

, p. 207 - 210 (2007/10/03)

Based on the hypothesis that the dose-limiting side effects of PDE4 inhibitors could be mediated via the central nervous system (CNS), design and synthesis of a hydrophilic analogue is considered to be one approach to improving the side-effect profile of

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 666179-93-7